Top
image credit: Marco Verch / Flickr

Single dose of Pfizer-BioNTech or Oxford-AstraZenca vaccine reduces infection rate by 65%, study finds

April 23, 2021

Via: CNBC
Category:

A single dose of Oxford-AstraZeneca or Pfizer-BioNTech’s Covid-19 vaccine drastically reduces the risk of infection in adults of all ages, British researchers have found.

Two studies released on Friday analyzed more than 1.6 million nose and throat swabs taken from 373,402 people between December and April. The data was collected as part of the ongoing Covid-19 Infection Survey, carried out by the University of Oxford, the U.K.‘s Office of National Statistics and the U.K.’s Department for Health and Social Care.

Read More on CNBC